Diabetes

Dapagliflozin improves glucose outcomes in type 1 diabetes

(HealthDay)—In patients with type 1 diabetes, treatment with dapagliflozin for 24 weeks improves time in range, mean glucose, and glycemic variability, according to a study published online April 9 in Diabetes Care.

Health

Technology poses no harm to nursing home residents

(Medical Xpress) -- The federal government is pushing doctors and hospitals to convert to electronic medical records by 2015, touting reductions in costs, increased patient safety and greater efficiencies in the U.S. health ...

page 12 from 40